301207.SZ
华兰疫苗
SZSE · Healthcare · C 制造业 · CN
CNY 17.08
−4.31%Margins
Gross margin
77.5%
EBITDA margin
27.5%
EBIT margin
16.1%
Net margin
15.6%
FCF margin
37.4%
3.3%
Return on equity
2.7%
Return on assets
—
Return on invested capital
0.18x
Asset turnover
CNY 460.8M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026